With Waters stockholders voting to issue shares, the companies are targeting a Feb. 9 close date for the deal.
BD, Waters set completion date for $17.5B biosciences and diagnostics merger
BD and Waters set Feb. 9 as the completion date for their $17.5 billion biosciences and diagnostics merger. BD will spin off its biosciences and diagnostics business and merge it with a Waters subsidiary, resulting in a combined company in which BD shareholders own 39.2%. Waters’ shareholders approved issuing stock, with broad turnout and overwhelming…